The Center for Stroke Research Berlin at the Charité – Universitätsmedizin Berlin has been funded since July 2008 as an Integrated Research and Treatment Center.
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.
Schlaganfall-Symptome; Vorstellung Beratungsstelle Servicepunkt Schlaganfall; zwei junge Schlaganfallbetroffene berichten
Your Support matters!
The CSB conducts research at the highest level and promotes young scientists. Optimal care of stroke as well as their close ones is also important to us. We are treading new paths in our quest to improve treatment and rehabilitation and thus raise the quality of life for people with stroke. Support our work with your donation.
